Trustmark National Bank Trust Department Cuts Position in UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Trustmark National Bank Trust Department lessened its stake in UnitedHealth Group Inc (NYSE:UNH) by 4.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,548 shares of the healthcare conglomerate’s stock after selling 128 shares during the quarter. Trustmark National Bank Trust Department’s holdings in UnitedHealth Group were worth $636,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Warren Averett Asset Management LLC increased its holdings in UnitedHealth Group by 10.6% during the 1st quarter. Warren Averett Asset Management LLC now owns 3,865 shares of the healthcare conglomerate’s stock valued at $964,000 after acquiring an additional 370 shares in the last quarter. united american securities inc. d b a uas asset management purchased a new position in UnitedHealth Group during the 1st quarter valued at about $5,063,000. Legal & General Group Plc boosted its stake in shares of UnitedHealth Group by 1.6% during the 1st quarter. Legal & General Group Plc now owns 6,218,799 shares of the healthcare conglomerate’s stock worth $1,551,937,000 after purchasing an additional 97,768 shares during the last quarter. Aviva PLC boosted its stake in shares of UnitedHealth Group by 0.6% during the 1st quarter. Aviva PLC now owns 886,002 shares of the healthcare conglomerate’s stock worth $220,951,000 after purchasing an additional 4,933 shares during the last quarter. Finally, APG Asset Management N.V. boosted its stake in shares of UnitedHealth Group by 305.2% during the 1st quarter. APG Asset Management N.V. now owns 2,315,539 shares of the healthcare conglomerate’s stock worth $509,899,000 after purchasing an additional 1,744,138 shares during the last quarter. Institutional investors and hedge funds own 86.59% of the company’s stock.

Shares of NYSE UNH traded down $18.55 during trading on Thursday, reaching $287.20. The company had a trading volume of 397,339 shares, compared to its average volume of 5,322,994. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $315.84. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.60. The company’s fifty day moving average price is $293.06 and its 200-day moving average price is $281.21. The stock has a market cap of $290.40 billion, a P/E ratio of 21.40, a PEG ratio of 1.54 and a beta of 0.72.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, April 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, topping the consensus estimate of $3.63 by $0.09. UnitedHealth Group had a return on equity of 24.86% and a net margin of 5.59%. The firm had revenue of $64.40 billion during the quarter, compared to the consensus estimate of $64.25 billion. During the same period in the prior year, the business posted $3.73 earnings per share. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Inc will post 16.24 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 22nd will be issued a $1.25 dividend. The ex-dividend date of this dividend is Friday, June 19th. This represents a $5.00 annualized dividend and a dividend yield of 1.74%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.08. UnitedHealth Group’s payout ratio is currently 28.59%.

UNH has been the topic of several analyst reports. Cowen raised their price target on shares of UnitedHealth Group from $320.00 to $340.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Wednesday, May 27th. SunTrust Banks lifted their price target on shares of UnitedHealth Group from $340.00 to $360.00 and gave the company a “buy” rating in a research report on Thursday, May 21st. Deutsche Bank reduced their price target on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating on the stock in a research report on Thursday, April 16th. Finally, Morgan Stanley lifted their price target on shares of UnitedHealth Group from $289.00 to $371.00 and gave the company an “overweight” rating in a research report on Thursday, April 30th. Four investment analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $323.13.

In other news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $237.00, for a total value of $1,185,000.00. Following the sale, the director now directly owns 1,406,500 shares of the company’s stock, valued at approximately $333,340,500. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Stephen J. Hemsley sold 45,637 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $289.11, for a total value of $13,194,113.07. Following the completion of the sale, the director now directly owns 1,013,122 shares in the company, valued at $292,903,701.42. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 65,637 shares of company stock worth $17,723,013. 0.80% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Trading Ex-Dividend Strategy

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply